Literature DB >> 18289566

Lithogenic risk factors in the morbidly obese population.

Branden G Duffey1, Renato N Pedro, Carly Kriedberg, Derek Weiland, Jonathan Melquist, Sayeed Ikramuddin, Todd Kellogg, Antoine A Makhlouf, Manoj Monga.   

Abstract

PURPOSE: To our knowledge baseline lithogenic risk factors in the morbidly obese population are currently unknown. Prior studies evaluated known stone formers and correlated risk with increasing body mass index. We describe risk factors for urinary stone formation in a group of unselected morbidly obese patients.
MATERIALS AND METHODS: Patients scheduled for gastric bypass provided a 24-hour urine collection before surgery. Patient demographics, medications and supplement consumption were recorded. A dietary intake diary was converted into daily kcal, Ca, Na and protein consumption. Differences between groups based on gender, history of diabetes or nephrolithiasis, diuretic use and Ca supplementation were evaluated. Correlation of stone risk parameters with body mass index was evaluated.
RESULTS: A total of 45 patients provided samples for analysis. Mean +/- SD body mass index was 49.5 +/- 9.1 kg/m(2) and mean age was 47.0 +/- 10.5 years. Overall 97.8% of patients had at least 1 lithogenic risk factor identified. Low urinary volume was the most common abnormality, affecting 71.1% of patients. Male patients excreted significantly more Ox (p = 0.0014), Na (p = 0.020), PO(4) (p = 0.0083) and SO(4) (p = 0.0014) than females. Patients with a history of nephrolithiasis excreted significantly more oxalate (p = 0.018) and had higher relative Na urate supersaturation (p = 0.00093) than nonstone formers. Hydrochlorothiazide use was associated with significantly increased Na urate relative supersaturation (p = 0.0097). Increasing body mass index was inversely associated with Mg (r = -0.38, p = 0.01) and brushite (r = -0.30, p = 0.04).
CONCLUSIONS: Of our cohort of morbidly obese patients 98% had at least 1 lithogenic risk factor identified on 24-hour urine collection. This study identified a high urinary stone risk in the morbidly obese and suggests possible avenues for dietary and/or pharmacological preventive measures. Future studies will determine how bariatric surgery alters these risk factors.

Entities:  

Mesh:

Year:  2008        PMID: 18289566     DOI: 10.1016/j.juro.2007.11.072

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  23 in total

1.  Obesity and Kidney Stone Procedures.

Authors:  Nikhi P Singh; Carter J Boyd; William Poore; Kyle Wood; Dean G Assimos
Journal:  Rev Urol       Date:  2020

Review 2.  Urinary stone disease and obesity: Different pathologies sharing common biochemical mechanisms.

Authors:  Ozgu Aydogdu
Journal:  World J Nephrol       Date:  2012-02-06

3.  Metabolic syndrome and urologic diseases.

Authors:  Ilya Gorbachinsky; Haluk Akpinar; Dean G Assimos
Journal:  Rev Urol       Date:  2010

4.  Diabetes mellitus and the risk of urolithiasis: a meta-analysis of observational studies.

Authors:  Lu Hao Liu; Ran Kang; Jun He; Shan Kun Zhao; Fu Tian Li; Zhi Gang Zhao
Journal:  Urolithiasis       Date:  2015-04-17       Impact factor: 3.436

5.  Urinary evaluation after RYGBP: a lithogenic profile with early postoperative increase in the incidence of urolithiasis.

Authors:  Antonio Carlos Valezi; Paulo Emilio Fuganti; Jorge Mali Junior; Vinicius Daher Delfino
Journal:  Obes Surg       Date:  2013-10       Impact factor: 4.129

Review 6.  Sky is no limit for ureteroscopy: extending the indications and special circumstances.

Authors:  Guido Giusti; Silvia Proietti; Roberto Peschechera; Gianluigi Taverna; Giuseppe Sortino; Luca Cindolo; Pierpaolo Graziotti
Journal:  World J Urol       Date:  2014-06-25       Impact factor: 4.226

7.  Body fat composition and occurrence of kidney stones in hypercalciuric children.

Authors:  Rose Ayoob; Wei Wang; Andrew Schwaderer
Journal:  Pediatr Nephrol       Date:  2011-06-10       Impact factor: 3.714

8.  The association of increasing body mass index and kidney stone disease.

Authors:  Michelle J Semins; Andrew D Shore; Martin A Makary; Thomas Magnuson; Roger Johns; Brian R Matlaga
Journal:  J Urol       Date:  2009-12-16       Impact factor: 7.450

9.  Hypocitraturia and hyperoxaluria after Roux-en-Y gastric bypass surgery.

Authors:  Naim M Maalouf; Prasanthi Tondapu; Eve S Guth; Edward H Livingston; Khashayar Sakhaee
Journal:  J Urol       Date:  2010-01-21       Impact factor: 7.450

10.  Effect of the body mass index on outcomes of flexible ureterorenoscopy.

Authors:  Erhan Sari; Abdulkadir Tepeler; Emrah Yuruk; Berkan Resorlu; Tolga Akman; Murat Binbay; Abdullah Armagan; Ali Unsal; Ahmet Yaser Muslumanoglu
Journal:  Urolithiasis       Date:  2013-07-23       Impact factor: 3.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.